华邦健康
(002004)
| 流通市值：80.61亿 | | | 总市值：84.74亿 |
| 流通股本：18.83亿 | | | 总股本：19.80亿 |
| 利润表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 营业总收入 | 2,818,702,693.62 | 11,512,347,207.84 | 9,085,988,424.34 | 5,945,032,088.09 |
| 营业总成本 | 2,516,630,644.28 | 10,357,705,761.77 | 8,097,647,440.81 | 5,353,287,909.61 |
| 其他经营收益 | | | | |
| 营业利润 | 321,919,910.81 | 1,046,585,823.93 | 1,061,070,480.48 | 666,675,477.11 |
| 利润总额 | 320,929,035.29 | 1,057,869,033.68 | 1,087,340,254.23 | 690,951,368.98 |
| 净利润 | 240,912,631.34 | 881,233,272.43 | 879,434,399.12 | 549,873,387.16 |
| 每股收益 | | | | |
| 其他综合收益 | -13,450,188.44 | 19,220,275.54 | 24,148,295.85 | 34,835,443.96 |
| 综合收益总额 | 227,462,442.9 | 900,453,547.97 | 903,582,694.97 | 584,708,831.12 |
| 资产负债表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 流动资产: | | | | |
| 流动资产合计 | 12,392,718,740.75 | 11,459,684,939.15 | 11,425,799,435.01 | 11,538,794,816.33 |
| 非流动资产: | | | | |
| 非流动资产合计 | 17,436,874,393.82 | 17,569,499,077.6 | 17,818,489,977.91 | 18,115,683,514.99 |
| 资产总计 | 29,829,593,134.57 | 29,029,184,016.75 | 29,244,289,412.92 | 29,654,478,331.32 |
| 流动负债: | | | | |
| 流动负债合计 | 8,862,336,519.03 | 9,113,408,329.01 | 8,526,767,570.66 | 9,379,962,735.7 |
| 非流动负债: | | | | |
| 非流动负债合计 | 3,632,604,157.29 | 2,936,361,449.76 | 4,618,910,667.46 | 4,310,669,907.01 |
| 负债合计 | 12,494,940,676.32 | 12,049,769,778.77 | 13,145,678,238.12 | 13,690,632,642.71 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 10,395,606,105.5 | 10,219,770,869.84 | 9,698,922,922.41 | 9,748,372,423.62 |
| 股东权益合计 | 17,334,652,458.25 | 16,979,414,237.98 | 16,098,611,174.8 | 15,963,845,688.61 |
| 负债和股东权益合计 | 29,829,593,134.57 | 29,029,184,016.75 | 29,244,289,412.92 | 29,654,478,331.32 |
| 现金流量表 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,503,123,562.08 | 10,639,159,173.63 | 7,694,740,278.16 | 4,829,415,881.62 |
| 经营活动现金流出小计 | 2,288,668,978.59 | 8,543,111,754.52 | 6,562,839,136.02 | 4,292,913,373.62 |
| 经营活动产生的现金流量净额 | 214,454,583.49 | 2,096,047,419.11 | 1,131,901,142.14 | 536,502,508 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 6,478,679,065.23 | 25,075,713,387.05 | 18,118,132,691.69 | 11,283,353,151.88 |
| 投资活动现金流出小计 | 6,286,669,205.82 | 26,354,004,059.23 | 18,567,747,294.92 | 11,019,371,576.17 |
| 投资活动产生的现金流量净额 | 192,009,859.41 | -1,278,290,672.18 | -449,614,603.23 | 263,981,575.71 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 1,968,661,249 | 7,743,552,564.6 | 6,853,542,011.82 | 3,922,475,643.62 |
| 筹资活动现金流出小计 | 1,221,698,173.3 | 9,021,761,927.27 | 7,824,555,093.11 | 4,439,882,953.56 |
| 筹资活动产生的现金流量净额 | 746,963,075.7 | -1,278,209,362.67 | -971,013,081.29 | -517,407,309.94 |
| 汇率变动对现金及现金等价物的影响 | -7,496,749.5 | 7,231,633.38 | 11,126,171.66 | 10,816,374.12 |
| 现金及现金等价物净增加额 | 1,145,930,769.1 | -453,220,982.36 | -277,600,370.72 | 293,893,147.89 |
| 期末现金及现金等价物余额 | 3,344,478,787.31 | 2,198,548,018.21 | 2,374,168,629.85 | 2,945,662,148.46 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -453,220,982.36 | - | 293,893,147.89 |